L
Lucy I.H. Overbeek
Researcher at Erasmus University Rotterdam
Publications - 12
Citations - 385
Lucy I.H. Overbeek is an academic researcher from Erasmus University Rotterdam. The author has contributed to research in topics: Grading (tumors) & Hazard ratio. The author has an hindex of 6, co-authored 12 publications receiving 294 citations.
Papers
More filters
Journal ArticleDOI
Lichen Sclerosus: Incidence and Risk of Vulvar Squamous Cell Carcinoma
TL;DR: This historical cohort showed a nearly 100% increase in incidence of lichen sclerosus between 1991 and 2011 and special attention is needed in particular in women with concurrent VIN because of their high risk of cancer.
Journal ArticleDOI
Offering self-sampling for human papillomavirus testing to non-attendees of the cervical screening programme: Characteristics of the responders.
Murat Gök,Daniëlle A.M. Heideman,Folkert J. van Kemenade,Anton L.M. de Vries,Johannes Berkhof,Lawrence Rozendaal,Jeroen A.M. Beliën,Lucy I.H. Overbeek,Milena Babović,Peter J.F. Snijders,Chris J.L.M. Meijer +10 more
TL;DR: Offering hrHPV self-sampling increases the efficacy of the screening programme by targeting a substantial portion of non-attendees of all ethnic groups who have not regularly been screened and are at highest risk of ≥ CIN2.
Journal ArticleDOI
Cumulative risks and rates of subsequent basal cell carcinomas in the Netherlands
S.C. Flohil,Senada Koljenović,E.R.M. de Haas,Lucy I.H. Overbeek,E.G.E. de Vries,Tamar Nijsten +5 more
TL;DR: This data indicates that the incidence of multiple basal cell carcinomas is not well documented and further research is needed to assess the importance of knowing the number and type of B cells in the abdomen.
Journal ArticleDOI
Significant inter- and intra-laboratory variation in grading of invasive breast cancer: A nationwide study of 33,043 patients in the Netherlands.
Carmen van Dooijeweert,Paul J. van Diest,Stefan M. Willems,C. Kuijpers,Elsken van der Wall,Lucy I.H. Overbeek,Ivette A. G. Deckers +6 more
TL;DR: In this cohort of 33,043 breast cancer patients, substantial inter‐ and intra‐laboratory variation in histologic grading is observed, and it can be anticipated that this has influenced outcome including exposure to unnecessary toxicity, since choice of adjuvant chemotherapy was dependent on grade in nearly a third of patients.
Journal ArticleDOI
Significant inter- and intra-laboratory variation in grading of ductal carcinoma in situ of the breast: a nationwide study of 4901 patients in the Netherlands.
Carmen van Dooijeweert,Paul J. van Diest,Stefan M. Willems,Chantal C H J Kuijpers,Lucy I.H. Overbeek,Ivette A. G. Deckers +5 more
TL;DR: There is an urgent need for nationwide standardization of grading practices for ductal carcinoma in situ (DCIS), especially since the future management of DCIS may alter significantly depending on histologic grade.